1 Introduction to Research & Analysis Reports
1.1 Glaucoma Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glaucoma Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glaucoma Treatment Drugs Overall Market Size
2.1 Global Glaucoma Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Glaucoma Treatment Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Glaucoma Treatment Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Glaucoma Treatment Drugs Players in Global Market
3.2 Top Global Glaucoma Treatment Drugs Companies Ranked by Revenue
3.3 Global Glaucoma Treatment Drugs Revenue by Companies
3.4 Global Glaucoma Treatment Drugs Sales by Companies
3.5 Global Glaucoma Treatment Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Glaucoma Treatment Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Glaucoma Treatment Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glaucoma Treatment Drugs Players in Global Market
3.8.1 List of Global Tier 1 Glaucoma Treatment Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Glaucoma Treatment Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Glaucoma Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral Type Glaucoma Treatment Drugs
4.1.3 Injection Type Glaucoma Treatment Drugs
4.2 By Type – Global Glaucoma Treatment Drugs Revenue & Forecasts
4.2.1 By Type – Global Glaucoma Treatment Drugs Revenue, 2018-2023
4.2.2 By Type – Global Glaucoma Treatment Drugs Revenue, 2024-2029
4.2.3 By Type – Global Glaucoma Treatment Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Glaucoma Treatment Drugs Sales & Forecasts
4.3.1 By Type – Global Glaucoma Treatment Drugs Sales, 2018-2023
4.3.2 By Type – Global Glaucoma Treatment Drugs Sales, 2024-2029
4.3.3 By Type – Global Glaucoma Treatment Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Glaucoma Treatment Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Glaucoma Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Care
5.2 By Application – Global Glaucoma Treatment Drugs Revenue & Forecasts
5.2.1 By Application – Global Glaucoma Treatment Drugs Revenue, 2018-2023
5.2.2 By Application – Global Glaucoma Treatment Drugs Revenue, 2024-2029
5.2.3 By Application – Global Glaucoma Treatment Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Glaucoma Treatment Drugs Sales & Forecasts
5.3.1 By Application – Global Glaucoma Treatment Drugs Sales, 2018-2023
5.3.2 By Application – Global Glaucoma Treatment Drugs Sales, 2024-2029
5.3.3 By Application – Global Glaucoma Treatment Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Glaucoma Treatment Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Glaucoma Treatment Drugs Market Size, 2022 & 2029
6.2 By Region – Global Glaucoma Treatment Drugs Revenue & Forecasts
6.2.1 By Region – Global Glaucoma Treatment Drugs Revenue, 2018-2023
6.2.2 By Region – Global Glaucoma Treatment Drugs Revenue, 2024-2029
6.2.3 By Region – Global Glaucoma Treatment Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Glaucoma Treatment Drugs Sales & Forecasts
6.3.1 By Region – Global Glaucoma Treatment Drugs Sales, 2018-2023
6.3.2 By Region – Global Glaucoma Treatment Drugs Sales, 2024-2029
6.3.3 By Region – Global Glaucoma Treatment Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Glaucoma Treatment Drugs Revenue, 2018-2029
6.4.2 By Country – North America Glaucoma Treatment Drugs Sales, 2018-2029
6.4.3 US Glaucoma Treatment Drugs Market Size, 2018-2029
6.4.4 Canada Glaucoma Treatment Drugs Market Size, 2018-2029
6.4.5 Mexico Glaucoma Treatment Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Glaucoma Treatment Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Glaucoma Treatment Drugs Sales, 2018-2029
6.5.3 Germany Glaucoma Treatment Drugs Market Size, 2018-2029
6.5.4 France Glaucoma Treatment Drugs Market Size, 2018-2029
6.5.5 U.K. Glaucoma Treatment Drugs Market Size, 2018-2029
6.5.6 Italy Glaucoma Treatment Drugs Market Size, 2018-2029
6.5.7 Russia Glaucoma Treatment Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Glaucoma Treatment Drugs Market Size, 2018-2029
6.5.9 Benelux Glaucoma Treatment Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Glaucoma Treatment Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Glaucoma Treatment Drugs Sales, 2018-2029
6.6.3 China Glaucoma Treatment Drugs Market Size, 2018-2029
6.6.4 Japan Glaucoma Treatment Drugs Market Size, 2018-2029
6.6.5 South Korea Glaucoma Treatment Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Glaucoma Treatment Drugs Market Size, 2018-2029
6.6.7 India Glaucoma Treatment Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Glaucoma Treatment Drugs Revenue, 2018-2029
6.7.2 By Country – South America Glaucoma Treatment Drugs Sales, 2018-2029
6.7.3 Brazil Glaucoma Treatment Drugs Market Size, 2018-2029
6.7.4 Argentina Glaucoma Treatment Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Glaucoma Treatment Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Glaucoma Treatment Drugs Sales, 2018-2029
6.8.3 Turkey Glaucoma Treatment Drugs Market Size, 2018-2029
6.8.4 Israel Glaucoma Treatment Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Glaucoma Treatment Drugs Market Size, 2018-2029
6.8.6 UAE Glaucoma Treatment Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Aerie Pharmaceuticals
7.1.1 Aerie Pharmaceuticals Company Summary
7.1.2 Aerie Pharmaceuticals Business Overview
7.1.3 Aerie Pharmaceuticals Glaucoma Treatment Drugs Major Product Offerings
7.1.4 Aerie Pharmaceuticals Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Aerie Pharmaceuticals Key News & Latest Developments
7.2 Akorn Inc.
7.2.1 Akorn Inc. Company Summary
7.2.2 Akorn Inc. Business Overview
7.2.3 Akorn Inc. Glaucoma Treatment Drugs Major Product Offerings
7.2.4 Akorn Inc. Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Akorn Inc. Key News & Latest Developments
7.3 Alcon
7.3.1 Alcon Company Summary
7.3.2 Alcon Business Overview
7.3.3 Alcon Glaucoma Treatment Drugs Major Product Offerings
7.3.4 Alcon Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Alcon Key News & Latest Developments
7.4 Allergan plc
7.4.1 Allergan plc Company Summary
7.4.2 Allergan plc Business Overview
7.4.3 Allergan plc Glaucoma Treatment Drugs Major Product Offerings
7.4.4 Allergan plc Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Allergan plc Key News & Latest Developments
7.5 Bausch & Lomb Incorporated
7.5.1 Bausch & Lomb Incorporated Company Summary
7.5.2 Bausch & Lomb Incorporated Business Overview
7.5.3 Bausch & Lomb Incorporated Glaucoma Treatment Drugs Major Product Offerings
7.5.4 Bausch & Lomb Incorporated Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Bausch & Lomb Incorporated Key News & Latest Developments
7.6 Inotek Pharmaceuticals
7.6.1 Inotek Pharmaceuticals Company Summary
7.6.2 Inotek Pharmaceuticals Business Overview
7.6.3 Inotek Pharmaceuticals Glaucoma Treatment Drugs Major Product Offerings
7.6.4 Inotek Pharmaceuticals Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Inotek Pharmaceuticals Key News & Latest Developments
7.7 Merck & Co. Inc
7.7.1 Merck & Co. Inc Company Summary
7.7.2 Merck & Co. Inc Business Overview
7.7.3 Merck & Co. Inc Glaucoma Treatment Drugs Major Product Offerings
7.7.4 Merck & Co. Inc Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Merck & Co. Inc Key News & Latest Developments
7.8 Pfizer Inc
7.8.1 Pfizer Inc Company Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc Glaucoma Treatment Drugs Major Product Offerings
7.8.4 Pfizer Inc Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Inc Key News & Latest Developments
7.9 Santen Pharmaceutical Co. Ltd
7.9.1 Santen Pharmaceutical Co. Ltd Company Summary
7.9.2 Santen Pharmaceutical Co. Ltd Business Overview
7.9.3 Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Major Product Offerings
7.9.4 Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Santen Pharmaceutical Co. Ltd Key News & Latest Developments
8 Global Glaucoma Treatment Drugs Production Capacity, Analysis
8.1 Global Glaucoma Treatment Drugs Production Capacity, 2018-2029
8.2 Glaucoma Treatment Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Glaucoma Treatment Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glaucoma Treatment Drugs Supply Chain Analysis
10.1 Glaucoma Treatment Drugs Industry Value Chain
10.2 Glaucoma Treatment Drugs Upstream Market
10.3 Glaucoma Treatment Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glaucoma Treatment Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の緑内障治療薬市場予測2023-2029：経口タイプ、注射タイプ |
| 【英語タイトル】Glaucoma Treatment Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5588 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：74 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の緑内障治療薬市場規模と予測を収録しています。・世界の緑内障治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の緑内障治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の緑内障治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口タイプ」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 緑内障治療薬のグローバル主要企業は、Aerie Pharmaceuticals、 Akorn Inc.、 Alcon、 Allergan plc、 Bausch & Lomb Incorporated、 Inotek Pharmaceuticals、 Merck & Co. Inc、 Pfizer Inc、 Santen Pharmaceutical Co. Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、緑内障治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の緑内障治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の緑内障治療薬市場：タイプ別市場シェア、2022年 ・経口タイプ、注射タイプ 世界の緑内障治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の緑内障治療薬市場：用途別市場シェア、2022年 ・病院、診療所、在宅医療 世界の緑内障治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の緑内障治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における緑内障治療薬のグローバル売上、2018年-2023年 ・主要企業における緑内障治療薬のグローバル売上シェア、2022年 ・主要企業における緑内障治療薬のグローバル販売量、2018年-2023年 ・主要企業における緑内障治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Aerie Pharmaceuticals、 Akorn Inc.、 Alcon、 Allergan plc、 Bausch & Lomb Incorporated、 Inotek Pharmaceuticals、 Merck & Co. Inc、 Pfizer Inc、 Santen Pharmaceutical Co. Ltd ************************************************************* ・調査・分析レポートの概要 緑内障治療薬市場の定義 市場セグメント 世界の緑内障治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の緑内障治療薬市場規模 世界の緑内障治療薬市場規模：2022年 VS 2029年 世界の緑内障治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの緑内障治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の緑内障治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：経口タイプ、注射タイプ 緑内障治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、在宅医療 緑内障治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別緑内障治療薬市場規模 2022年と2029年 地域別緑内障治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Aerie Pharmaceuticals、 Akorn Inc.、 Alcon、 Allergan plc、 Bausch & Lomb Incorporated、 Inotek Pharmaceuticals、 Merck & Co. Inc、 Pfizer Inc、 Santen Pharmaceutical Co. Ltd ... |
This report aims to provide a comprehensive presentation of the global market for Glaucoma Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Treatment Drugs. This report contains market size and forecasts of Glaucoma Treatment Drugs in global, including the following market information:
Global Glaucoma Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Glaucoma Treatment Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Glaucoma Treatment Drugs companies in 2022 (%)
The global Glaucoma Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Type Glaucoma Treatment Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Glaucoma Treatment Drugs include Aerie Pharmaceuticals, Akorn Inc., Alcon, Allergan plc, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co. Inc, Pfizer Inc and Santen Pharmaceutical Co. Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glaucoma Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glaucoma Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Oral Type Glaucoma Treatment Drugs
Injection Type Glaucoma Treatment Drugs
Global Glaucoma Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Home Care
Global Glaucoma Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glaucoma Treatment Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Glaucoma Treatment Drugs revenues share in global market, 2022 (%)
Key companies Glaucoma Treatment Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Glaucoma Treatment Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aerie Pharmaceuticals
Akorn Inc.
Alcon
Allergan plc
Bausch & Lomb Incorporated
Inotek Pharmaceuticals
Merck & Co. Inc
Pfizer Inc
Santen Pharmaceutical Co. Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glaucoma Treatment Drugs, market overview.
Chapter 2: Global Glaucoma Treatment Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Glaucoma Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glaucoma Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glaucoma Treatment Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の緑内障治療薬市場予測2023-2029：経口タイプ、注射タイプ] (コード：MMG23JU5588)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の緑内障治療薬市場予測2023-2029：経口タイプ、注射タイプ]についてメールでお問い合わせ |
